Search

everythinglearnresearchcommunity

for

Search:↓

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Blocking both P-cadherin and c-Met can effectively stop head and neck cancer growth.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

Antibodies help identify glycoproteins in normal skin and tumor cells.

Blocking interferon-gamma might help treat various autoimmune diseases.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Increased Stat3 activity reduces hair follicle stem cells and boosts other stem/progenitor cells.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Targeting colon cancer stem cells might lead to better treatment results.

CD133+ progenitor cells have therapeutic potential for diabetic ulcers and heart attack recovery, with manageable risks.

Tcf3 and Lef1 are key in deciding skin stem cell roles.

Overexpressing NSD3 in mice causes breast cancer-like tumors and gland abnormalities.

Toluene diisocyanate exposure can cause immune sensitization by interacting with proteins in hair follicles and sebaceous glands.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Autoimmune reactions may cause both alopecia areata and HAM.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Overexpressing Merkel cell virus proteins in human hair follicles can create clusters of cells that resemble Merkel cell cancer.